Couñago Lorenzo, FelipeGonzález, CarmenGómez Iturriaga, AlfonsoÁlvarez, AnaSantos, MarinaBoladeras-Inglada, A. M.García, NagoreFernández, SandraGonsalves, DanielaDuque Santana, VíctorEt.al.2026-10-052026-10-052026Couñago, F., González, C., Gómez-Iturriaga, A., Álvarez, A., Santos, M., Boladeras, A., García, N., Fernández, S., Guardado, S., Ocanto, A., Gonsalves, D., Glaría, L., Castaño, A., Martín, P., Montezuma, L., Mera, A., Mases, J., Meca, G., Duque-Santana, V., … López-Campos, F. (2026). Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial. Clinical and Translational Radiation Oncology, 61, 101276. https://doi.org/10.1016/j.ctro.2026.1012762405-6308https://hdl.handle.net/11268/17458Moderate hypofractionation is increasingly used in salvage radiotherapy (SRT) after radical prostatectomy, although prospective data in the postoperative setting remain limited. We evaluated early adverse events and patient-reported outcomes (PROs) according to fractionation schedule within a prospective multicenter phase III trial.engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/MedicinaNeoplasias de la PróstataTerapia RecuperativaEfectos Colaterales y Reacciones Adversas Relacionados con Medicamentosjournal article10.1016/j.ctro.2026.101276open accessCáncerHombreTratamiento médicoGoal 3: Ensure healthy lives and promote well-being for all at all ages